about
Comparison of RNA extraction methods from biofilm samples of Staphylococcus epidermidis.The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood.Differentiation of Staphylococcus argenteus (formerly: Staphylococcus aureus clonal complex 75) by mass spectrometry from S. aureus using the first strain isolated from a wild African great ape.Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.Bacteriophage-encoded depolymerases: their diversity and biotechnological applications.Molecular aspects and comparative genomics of bacteriophage endolysins.Complete Genome Sequence of the Broad-Host-Range Paenibacillus larvae Phage phiIBB_Pl23Isolation and characterization of a new Staphylococcus epidermidis broad-spectrum bacteriophage.Correction: The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood.Synergistic Antimicrobial Interaction between Honey and Phage against Escherichia coli Biofilms.In Vitro Activity of Bacteriophages Against Planktonic and Biofilm Populations Assessed by Flow Cytometry.Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections.Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms.Controlled RNA contamination and degradation and its impact on qPCR gene expression in S. epidermidis biofilms.Control of Salmonella Enteritidis on food contact surfaces with bacteriophage PVP-SE2Staphylococci phages display vast genomic diversity and evolutionary relationshipsEfficacy and safety assessment of two enterococci phages in an in vitro biofilm wound modelIdentification of the first endolysin Cell Binding Domain (CBD) targeting Paenibacillus larvaePhage therapy efficacy: a review of the last 10 years of preclinical studiesAssessment of Sep1virus interaction with stationary cultures by transcriptional and flow cytometry studiesChestnut Honey and Bacteriophage Application to Control Pseudomonas aeruginosa and Escherichia coli Biofilms: Evaluation in an ex vivo Wound ModelEncapsulated bacteriophages in alginate-nanohydroxyapatite hydrogel as a novel delivery system to prevent orthopedic implant-associated infectionsSynergistic Action of Phage and Antibiotics: Parameters to Enhance the Killing Efficacy Against Mono and Dual-Species BiofilmsCharacterization of a new podovirus infecting Paenibacillus larvaeLytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections
P50
Q34114510-D95FDB2E-9816-4FC0-BEFE-4FAF748BF9DAQ35689447-0EAE066A-6F2E-4CE8-A3BD-23F99747678EQ36216691-F6C9E14A-D709-4CF6-8341-6CA41426CFB8Q37043292-7D2A833B-7838-432F-B027-D47F3803FFA7Q38696760-801E759C-ADBD-49BF-8866-7C5E03931E1EQ39793850-A76F34B5-3FA8-4941-9809-5A62B82E5AB1Q42141877-8835A1BC-910F-4A77-9C8B-60CEF90EB610Q42257796-6D44DEB5-25E3-4F09-ABED-1302C9E86094Q42533070-5106D111-5C3D-476B-B182-41906D12C000Q47140891-FFBCF5F1-50B6-448D-8C49-E6AE449C4355Q47366882-D5B1DDBF-1E23-407A-AEDD-7B834F7823D5Q47614389-8BBDB86A-8BC0-41E1-B289-53E9F35E26E9Q52593684-0883A47A-45D1-4442-874E-E55C85906EA5Q54245108-FC147D79-C574-433E-BEC8-58DBD93D5153Q60649748-53839DFA-F675-4F65-88C1-4BEC91909F80Q64059546-93D4DB99-70F1-4A16-9967-B4F298C9FFF8Q64080389-351F502F-3875-4150-8908-1769A756784DQ64116287-DFE3EBE6-6C19-4B6F-B026-147318BDCC9CQ89854854-57DFD33D-3F07-48B4-91E5-52C5E3D9C779Q90636707-5E8A0F5F-09B9-459D-A46B-845D3984A99EQ90948426-A5912285-EB7A-45BF-A1AD-948B4444DCBAQ92130262-2B15DC4E-B029-41FE-AA70-3674272DA3C6Q92210060-C9B16607-CF6F-4EBB-BBB7-E7CB907AFE1DQ92335365-ED31166B-19F4-4AAB-B625-45C54318BEA1Q92960439-DCF5C61B-A0D2-4F0B-B6A3-DFF0AC7DFA57
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6865-6044
@en
name
Luís Melo
@ast
Luís Melo
@en
Luís Melo
@es
Luís Melo
@nl
type
label
Luís Melo
@ast
Luís Melo
@en
Luís Melo
@es
Luís Melo
@nl
prefLabel
Luís Melo
@ast
Luís Melo
@en
Luís Melo
@es
Luís Melo
@nl
P108
P106
P1153
54896627700
P31
P496
0000-0002-6865-6044